Proposals for making the clinical guideline development process more efficient
Changes to the process for developing clinical guidelines
The NICE Board approved the changes to the process for developing clinical guidelines at its public meeting on 21 September 2011. Please see the Board paper for further information.
The key changes approved are as follows:
- Reduction of the draft clinical guideline public consultation period from 8 weeks to 6 weeks.
- A number of documents will be published for information at a defined point during development; these will include the finalised health economic plan, the review questions and search strategies.
Guideline Review Panels (GRPs)
- Removal of the sign off process of the scope by the GRPs
- Removal of the sign off process of the final guideline by the GRPs
- The Guideline Commissioning Manager and Associate Director lead will continue to monitor that the scope and process have been followed and will ensure that the developers have responded adequately and appropriately to stakeholder comments
- Removal of the 3 week pre-publication check and associated processes.
- A pre-publication embargoed version of the guideline along with the stakeholder comments table will be sent to registered stakeholders who commented on the guideline before publication.
Key documents (to follow)
This page was last updated: 29 December 2011